Pharmacokinetics, Biodistribution, Acute Toxicity and In Vivo Anti-tumour Efficacy of Paclitaxel Solid Dispersion

被引：0
|
作者：
Liu, Xiangrui [2 ,3 ]
Sun, Jiabei [2 ]
Chen, Xiaomei [2 ]
Wang, Shudong [1 ,3 ]
Zhang, Xuan [2 ]
Zhang, Qiang [2 ]
机构：
[1] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England
[2] Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100083, Peoples R China
[3] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2010年 / 62卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1234 / 1235
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion
    Liu, Xiangrui
    Sun, Jiabei
    Chen, Xiaomei
    Wang, Shanshan
    Scott, Hannah
    Zhang, Xuan
    Zhang, Qiang
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (06) : 775 - 782
  • [2] In vivo safety, toxicity, biocompatibility and anti-tumour efficacy of bioinspired silver and selenium nanoparticles
    Mittal, Amit Kumar
    Banerjee, Uttam Chand
    MATERIALS TODAY COMMUNICATIONS, 2021, 26
  • [3] In Vivo Pharmacokinetics, Pharmacodynamics and Anti-tumour Efficacy of EXS74539: A Novel, Reversible LSD1 Inhibitor for Acute Myeloid Leukaemia
    Okumura, R.
    Thatikonda, V.
    Lautizi, M.
    Hieger, N.
    Senekowitsch, M.
    Lin, T. Y.
    Fiume, G.
    Winkler-Penz, T.
    Payne, A.
    Wilde, T.
    Dominguez, M.
    Muellers, E.
    Boudesco, C.
    Krall, N.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S96 - S97
  • [4] The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia
    Tomalova, Barbora
    Sirova, Milada
    Rossmann, Pavel
    Pola, Robert
    Strohalm, Jiri
    Chytil, Petr
    Cerny, Viktor
    Tomala, Jakub
    Kabesova, Martina
    Rihova, Blanka
    Ulbrich, Karel
    Etrych, Tomas
    Kovar, Marek
    JOURNAL OF CONTROLLED RELEASE, 2016, 223 : 1 - 10
  • [5] Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy
    Kawashiri, Takehiro
    Egashira, Nobuaki
    Itoh, Yoshinori
    Shimazoe, Takao
    Ikegami, Yoko
    Yano, Takahisa
    Yoshimura, Megumu
    Oishi, Ryozo
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 154 - 163
  • [6] Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor
    Ben-Horin, S.
    Ungar, B.
    Kopylov, U.
    Lahat, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Peled, Y.
    Eliakim, R.
    Del Tedesco, E.
    Paul, S.
    Roblin, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (08) : 1117 - 1125
  • [7] Toxicity and anti-tumour efficacy of oxaliplatin on Glasgow Osteosarcoma in mice:: a mathematical model.
    Clairambault, J
    Claude, D
    Filipski, E
    Granda, T
    Lévi, F
    PATHOLOGIE BIOLOGIE, 2003, 51 (04): : 212 - 215
  • [8] Enhancing anti-tumour efficacy with immunotherapy combinations
    Meric-Bernstam, Funda
    Larkin, James
    Tabernero, Josep
    Bonini, Chiara
    LANCET, 2021, 397 (10278): : 1010 - 1022
  • [9] Fluorouracil can significantly inhibit the anti-tumour effect of paclitaxel
    Reactions Weekly, 1997, 676 (1) : 5 - 5
  • [10] The role of size in PEGylated liposomal doxorubicin biodistribution and anti-tumour activity
    Dadpour, Saba
    Mehrabian, Amin
    Arabsalmani, Mahdieh
    Mirhadi, Elaheh
    Askarizadeh, Anis
    Mashreghi, Mohammad
    Jaafari, Mahmoud Reza
    IET NANOBIOTECHNOLOGY, 2022, 16 (7-8) : 259 - 272
12345